PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
+30.71%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$4.66B
AUM Growth
+$4.66B
Cap. Flow
-$219M
Cap. Flow %
-4.69%
Top 10 Hldgs %
46.73%
Holding
123
New
13
Increased
23
Reduced
25
Closed
18

Top Buys

1
VRNA
Verona Pharma
VRNA
$112M
2
VKTX icon
Viking Therapeutics
VKTX
$62M
3
ARGX icon
argenx
ARGX
$56M
4
NUVL icon
Nuvalent
NUVL
$44M
5
CNTA
Centessa Pharmaceuticals
CNTA
$37.6M

Top Sells

1
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$441M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
$74.1M
3
NBIX icon
Neurocrine Biosciences
NBIX
$50.4M
4
NTRA icon
Natera
NTRA
$39.4M
5
CRNX icon
Crinetics Pharmaceuticals
CRNX
$38.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BCYC
76
Bicycle Therapeutics
BCYC
$511M
$5.79M 0.12% 255,994 -316,006 -55% -$7.15M
VERU icon
77
Veru
VERU
$47.6M
$5.6M 0.12% 7,283,157 +219,880 +3% +$169K
BBOT
78
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$708M
$5.22M 0.11% 500,000 – –
BDSX icon
79
Biodesix
BDSX
$62.6M
$3.87M 0.08% 2,173,880 – –
DTIL icon
80
Precision BioSciences
DTIL
$57.8M
$3.82M 0.08% 426,293 – –
MREO
81
Mereo BioPharma
MREO
$272M
$3.35M 0.07% 815,722 -437,528 -35% -$1.8M
LYRA icon
82
Lyra Therapeutics
LYRA
$11.5M
$3.28M 0.07% 12,757,562 – –
NBTX
83
Nanobiotix
NBTX
$429M
$3.19M 0.07% 555,066 – –
ABSI icon
84
Absci
ABSI
$357M
$2.67M 0.06% 700,000 – –
ATHA icon
85
Athira Pharma
ATHA
$15.3M
$2.41M 0.05% 5,402,964 – –
XFOR icon
86
X4 Pharmaceuticals
XFOR
$84.2M
$2.37M 0.05% 3,545,454 – –
NVNO icon
87
enVVeno Medical
NVNO
$15.4M
$2.33M 0.05% 694,315 +71,000 +11% +$239K
KYMR icon
88
Kymera Therapeutics
KYMR
$2.95B
$2.19M 0.05% +46,213 New +$2.19M
TRIB
89
Trinity Biotech
TRIB
$5.44M
$1.98M 0.04% 1,800,000 – –
PYXS icon
90
Pyxis Oncology
PYXS
$79.4M
$1.87M 0.04% +508,462 New +$1.87M
IRTC icon
91
iRhythm Technologies
IRTC
$5.46B
$1.68M 0.04% 22,591 -12,614 -36% -$936K
GPCR icon
92
Structure Therapeutics
GPCR
$1.11B
$1.53M 0.03% 34,852 – –
LXEO icon
93
Lexeo Therapeutics
LXEO
$259M
$1.26M 0.03% +139,835 New +$1.26M
FATE icon
94
Fate Therapeutics
FATE
$120M
$1.21M 0.03% 345,575 – –
OMIC
95
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$798K 0.02% 50,896 -20,000 -28% -$313K
KYTX icon
96
Kyverna Therapeutics
KYTX
$160M
$734K 0.02% 150,000 – –
FBRX icon
97
Forte Biosciences
FBRX
$137M
$535K 0.01% 95,742 -3,169,617 -97% -$17.7M
SYRS
98
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$251K 0.01% 116,754 – –
CMAX
99
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$170K ﹤0.01% 100,000 -22,643 -18% -$38.5K
RVMDW icon
100
Revolution Medicines, Inc. Warrant
RVMDW
$1.82M
$35K ﹤0.01% 250,000 – –
1 2 3
4
5